Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      China launches nationwide action after faulty rabies vaccine

      China launches nationwide action after faulty rabies vaccine

      Ruby Khatun Khatun12 Aug 2018 9:30 AM IST
      With the recent faulty rabies vaccine scandal creating panic, China has launched a nationwide campaign to provide medical consultation and free...
      Daiichi-Ranbaxy row: Singh brothers restrained from using bank accounts by HC

      Daiichi-Ranbaxy row: Singh brothers restrained from using bank accounts by HC

      Ruby Khatun Khatun11 Aug 2018 12:58 PM IST
      New Delhi: The Delhi High Court restrained former Ranbaxy Laboratories Ltd promoters Malvinder and Shivinder Singh from operating their bank accounts...
      AstraZeneca receives nod to import, market cancer drug

      AstraZeneca receives nod to import, market cancer drug

      Ruby Khatun Khatun11 Aug 2018 11:00 AM IST
      New Delhi: AstraZeneca Pharma India said it has received import and market permission from the Drug Controller General of India (DCGI) for Osimertinib...
      FDA approves Poteligeo injection for two rare types of non-Hodgkin lymphoma

      FDA approves Poteligeo injection for two rare types of non-Hodgkin lymphoma

      Ruby Khatun Khatun11 Aug 2018 10:45 AM IST
      The U.S. Food and Drug Administration (FDA) approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients...
      Cipla Q1 net profit up 10 percent at Rs 451 crore

      Cipla Q1 net profit up 10 percent at Rs 451 crore

      Ruby Khatun Khatun11 Aug 2018 10:30 AM IST
      New Delhi: Drug major Cipla posted 10 percent increase in its consolidated net profit to Rs 451 crore for the first quarter ended June 30, driven by...
      Pharma exports up 3 percent to USD 17.3 billion in 2017-18

      Pharma exports up 3 percent to USD 17.3 billion in 2017-18

      Ruby Khatun Khatun11 Aug 2018 10:15 AM IST
      New Delhi: India's pharmaceutical exports grew merely 3 percent to USD 17.3 billion in 2017-18 due to increasing regulatory concerns and pricing...
      US joins lawsuits against Indivior, Reckitt over drug Suboxone

      US joins lawsuits against Indivior, Reckitt over drug Suboxone

      Ruby Khatun Khatun11 Aug 2018 9:45 AM IST
      The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the...
      Recalling defective vaccines will deal heavy blow to Chinas drug exports: experts

      Recalling defective vaccines will deal heavy blow to China's drug exports: experts

      Ruby Khatun Khatun11 Aug 2018 9:30 AM IST
      New Delhi: China's recalling of the defective vaccines and special category drugs from home and abroad, including India, over safety concerns, will...
      Pfizers Viagra patent set to end in US, Indian Pharma eyes Opportunity

      Pfizers Viagra patent set to end in US, Indian Pharma eyes Opportunity

      Ruby Khatun Khatun10 Aug 2018 2:55 PM IST
      New Delhi: Pharma Giant Pfizer is soon going to lose patent of its blockbuster drug Viagra in the US and this indeed is coming as a strong opportunity...
      Natco Pharma Q1 net profit up 93 percent to Rs 181 crore

      Natco Pharma Q1 net profit up 93 percent to Rs 181 crore

      Ruby Khatun Khatun10 Aug 2018 11:00 AM IST
      New Delhi: Drug firm Natco Pharma reported a 93.27 percent rise in its consolidated net profit to Rs 181.1 crore for the quarter ended June 30 mainly...
      Lupin Q1 net profit dips 43 percent at Rs 203 crore

      Lupin Q1 net profit dips 43 percent at Rs 203 crore

      Ruby Khatun Khatun10 Aug 2018 10:45 AM IST
      New Delhi: Drug firm Lupin reported 43.37 percent decline in its consolidated net profit at Rs 202.76 crore for the first quarter ended June 30, hit...
      Glenmarks partner Elite gets USFDA approval for opioid analgesic drug

      Glenmark's partner Elite gets USFDA approval for opioid analgesic drug

      Ruby Khatun Khatun10 Aug 2018 10:30 AM IST
      New Delhi: Glenmark Pharmaceuticals said its partner Elite Pharmaceuticals Inc has received approval from the US health regulator for generic opioid...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok